Sanofi to Produce Millions of Vaccines for Rival Company

Its own vaccine candidate faces delays.

Screen Shot 2021 02 22 At 9 08 34 Am
iStock

PARIS (AP) β€” Sanofi is going to produce as many as 12 million coronavirus vaccine doses per month for rival Johnson & Johnson, the second time the French drug maker is turning over production facilities to speed up supplies of a rival company’s vaccine, while its own candidate faces delays.

Sanofi’s announcement on Monday was quickly trumpeted by French President Emmanuel Macron, who relayed the development on his Twitter account. β€œWe must together accelerate the production of vaccines with industrial partnerships,” Macron tweeted.

Sanofi said its vaccine manufacturing plant in Marcy l’Etoile, France, will formulate and fill vials of Johnson & Johnson’s vaccine candidate, developed by its Janssen companies. Sanofi said its French plant is expected to produce about 12 million doses per month of the single-dose vaccine.

Sanofi’s CEO, Paul Hudson, said the company remains committed to its own two COVID-19 vaccine programs but is also β€œstepping forward to show solidarity.” Sanofi has already previously announced that it will help bottle and package 125 million vaccine doses for the rival partnership of Pfizer-BioNTech.

More in Product Development